These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


394 related items for PubMed ID: 22162141

  • 1. StarClose vascular closure system (VCS) is safe and effective in patients who ambulate early following successful femoral artery access closure--results from the RISE clinical trial.
    Burke MN, Hermiller J, Jaff MR.
    Catheter Cardiovasc Interv; 2012 Jul 01; 80(1):45-52. PubMed ID: 22162141
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of clip-based vs. suture mediated vascular closure for femoral access hemostasis: A prospective randomized single center study comparing the StarClose and the ProGlide device.
    Klein-Wiele O, Baliota M, Kara K, Käunicke M, Schäfer H, Garbrecht M, Abdulghafor M, Garmer M, Hailer B.
    Catheter Cardiovasc Interv; 2018 Feb 15; 91(3):402-407. PubMed ID: 28500743
    [Abstract] [Full Text] [Related]

  • 3. The use of the StarClose device for obtaining femoral artery hemostasis.
    Rodriguez A, Katz SG.
    Vasc Endovascular Surg; 2011 Oct 15; 45(7):627-30. PubMed ID: 21646232
    [Abstract] [Full Text] [Related]

  • 4. Accelerated ambulation after vascular access closure device.
    Brancheau D, Sarsam S, Assaad M, Zughaib M.
    Ther Adv Cardiovasc Dis; 2018 May 15; 12(5):141-144. PubMed ID: 29421959
    [Abstract] [Full Text] [Related]

  • 5. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial).
    Wong SC, Bachinsky W, Cambier P, Stoler R, Aji J, Rogers JH, Hermiller J, Nair R, Hutman H, Wang H, ECLIPSE Trial Investigators.
    JACC Cardiovasc Interv; 2009 Aug 15; 2(8):785-93. PubMed ID: 19695549
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of the nitinol clip-based vascular closure device (Starclose) for closure of common femoral arterial cannulation at or near the bifurcation: a propensity score-adjusted analysis.
    Bangalore S, Vidi VD, Liu CB, Shah PB, Resnic FS.
    J Invasive Cardiol; 2011 May 15; 23(5):194-9. PubMed ID: 21562348
    [Abstract] [Full Text] [Related]

  • 7. The CLOSER trial: a multi-center study on the clinical safety and effectiveness of CloserTM VSS, a novel resorbable transfemoral vascular access sealing system.
    Wong SC, Gammon R, Bachinsky W, O'Shaughnessy C, Leimbach W, Bernardo N, Cavros N, Jaff MR, Liu PY, Bergman G.
    Catheter Cardiovasc Interv; 2017 Nov 01; 90(5):798-805. PubMed ID: 28833996
    [Abstract] [Full Text] [Related]

  • 8. Early ambulation after percutaneous femoral access with use of closure devices and hemostatic agents.
    Engelbert TL, Scholten A, Thompson K, Spivack A, Kansal N.
    Ann Vasc Surg; 2010 May 01; 24(4):518-23. PubMed ID: 20451795
    [Abstract] [Full Text] [Related]

  • 9. The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study.
    Jaff MR, Hadley G, Hermiller JB, Simonton C, Hinohara T, Cannon L, Reisman M, Braden G, Fletcher DR, Zapien M, Chou TM, DiDonato K.
    Catheter Cardiovasc Interv; 2006 Nov 01; 68(5):684-9. PubMed ID: 17039509
    [Abstract] [Full Text] [Related]

  • 10. Angioseal VIP® vs. StarClose SE® closure devices: a comparative analysis in non-cardiological procedures.
    Lucatelli P, Fanelli F, Cannavale A, Corona M, Cirelli C, D'Adamo A, Salvatori FM, Catalano C.
    J Cardiovasc Surg (Torino); 2017 Feb 01; 58(1):80-86. PubMed ID: 24309473
    [Abstract] [Full Text] [Related]

  • 11. The utility of the StarClose arterial closure device in patients with peripheral arterial disease.
    Gray BH, Miller R, Langan EM, Joels CS, Yasin Y, Kalbaugh CA.
    Ann Vasc Surg; 2009 Feb 01; 23(3):341-4. PubMed ID: 18809287
    [Abstract] [Full Text] [Related]

  • 12. The StarClose Vascular Closure System: interventional results from the CLIP study.
    Hermiller JB, Simonton C, Hinohara T, Lee D, Cannon L, Mooney M, O'Shaughnessy C, Carlson H, Fortuna R, Zapien M, Fletcher DR, DiDonato K, Chou TM.
    Catheter Cardiovasc Interv; 2006 Nov 01; 68(5):677-83. PubMed ID: 17039508
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of the StarClose vascular closure device in more than 1000 consecutive peripheral angioplasty procedures.
    Spiliopoulos S, Katsanos K, Karnabatidis D, Diamantopoulos A, Nikolaos C, Siablis D.
    J Endovasc Ther; 2011 Jun 01; 18(3):435-43. PubMed ID: 21679086
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of StarClose SE Vascular Closure System in high-risk liver interventional oncology patients.
    Gaba RC, Parvinian A, Trinos EM, Padayao SV, Francisco RM, Yap FY, Knuttinen MG, Owens CA, Bui JT.
    J Vasc Access; 2012 Jun 01; 13(4):415-20. PubMed ID: 22467152
    [Abstract] [Full Text] [Related]

  • 15. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Saleh N, De Palma R, Settergren M, Rück A.
    Catheter Cardiovasc Interv; 2015 Dec 01; 86(7):1255-61. PubMed ID: 26332528
    [Abstract] [Full Text] [Related]

  • 16. Safety and effectiveness of a novel vascular closure device: a prospective study of the ExoSeal compared to the Angio-Seal and ProGlide.
    Kara K, Mahabadi AA, Rothe H, Müller P, Krüger J, Neubauer H, Klein-Wiele O, Mügge A, Kahlert P, Erbel R.
    J Endovasc Ther; 2014 Dec 01; 21(6):822-8. PubMed ID: 25453885
    [Abstract] [Full Text] [Related]

  • 17. A multicenter randomized trial comparing the effectiveness and safety of a novel vascular closure device to manual compression in anticoagulated patients undergoing percutaneous transfemoral procedures: The CELT ACD trial.
    Wong SC, Laule M, Turi Z, Sanad W, Crowley J, Degen H, Bennett K, Coleman JE, Bergman G.
    Catheter Cardiovasc Interv; 2017 Nov 01; 90(5):756-765. PubMed ID: 28296003
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thermic sealing in femoral catheterization: First experience with the Secure Device.
    Sacherer M, Kolesnik E, von Lewinski F, Verheyen N, Brandner K, Wallner M, Eaton DM, Luha O, Zweiker R, von Lewinski D.
    Cardiol J; 2019 Nov 01; 26(3):233-240. PubMed ID: 29611164
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.